07:00 , Aug 15, 2016 |  BioCentury  |  Finance

De-risking first in class

Cleave Biosciences Inc. has steered clear of non-dilutive partnership dollars in hopes of internally validating the profile of its first-in-class cancer therapeutic CB-5083 . Now, the biotech has attracted a cadre of new investors in...
07:00 , Aug 15, 2016 |  BC Week In Review  |  Financial News

Cleave Biosciences completes venture financing

Cleave Biosciences Inc. , Burlingame, Calif.   Business: Cancer   Date completed: 2016-08-08   Type: Venture financing   Raised: $37 million   Investors: Celgene Corp. ; Nextech Invest; Arcus Ventures; 5AM Ventures; Clarus ; New...
07:00 , Aug 8, 2016 |  BC Extra  |  Top Story

Cleave raises $37M in series B

Cleave Biosciences Inc. (Burlingame, Calif.) raised $37 million in a series B round. New investors Celgene Corp. (NASDAQ:CELG), Nextech Invest and Arcus Ventures joined existing investors 5AM Ventures, Clarus , New Enterprise Associates, OrbiMed Advisors,...
02:21 , Jan 8, 2016 |  BC Extra  |  Financial News

Diagnostics plays Guardant, Exosome close private rounds

Two companies in the minimally invasive, fluid-based diagnostics sector announced private funding rounds on Thursday. Guardant Health Inc. (Redwood City, Calif.) said it raised the majority of a planned $100 million series D round. New...
07:00 , Sep 7, 2015 |  BC Week In Review  |  Financial News

Exosome Diagnostics financial update

Exosome Diagnostics Inc. , Cambridge, Mass.   Business: Diagnostic, Cancer   Date announced: 2015-09-02   Note: Exosome raised $17.6 million in an extension of a series B round, bringing the total raised in the round...
07:00 , Jun 15, 2015 |  BC Week In Review  |  Financial News

Xtuit completes venture financing

Xtuit Pharmaceuticals Inc. , Cambridge, Mass.   Business: Cancer, Hepatic   Date completed: 2015-06-11   Type: Venture financing   Raised: $22 million   Investors: New Enterprise Associates; Polaris Partners; CTI Life Sciences Fund; Arcus Ventures;...
01:06 , Jun 12, 2015 |  BC Extra  |  Financial News

XTuit raises $22 million in series A

XTuit Pharmaceuticals Inc. (Cambridge, Mass.) raised $22 million in a series A round led by New Enterprise Associates. New investors CTI Life Sciences, Arcus Ventures and Omega Funds also participated, as did founding investor Polaris...
07:00 , Sep 29, 2014 |  BC Week In Review  |  Financial News

Tracon completes venture financing

Tracon Pharmaceuticals Inc. , San Diego, Calif.   Business: Cancer   Date completed: 2014-09-22   Type: Venture financing   Raised: $27 million   Investors: New Enterprise Associates; BioMed Venture; institutional investor; JAFCO; Nextech Invest; Brookline...
03:09 , Sep 23, 2014 |  BC Extra  |  Financial News

Tracon raises $27M in B round

Tracon Pharmaceuticals Inc. (San Diego, Calif.) raised $27 million in a series B round led by New Enterprise Associates. Additional new investors included BioMed Ventures and an undisclosed institutional investor. Existing investors JAFCO; Nextech Invest;...
07:00 , Aug 18, 2014 |  BC Week In Review  |  Financial News

Arcus Ventures financial update

Arcus Ventures , New York, N.Y.   Business: Finance   Date announced: 2014-08-08   Note: Arcus Ventures raised $10 million in a second close of its Arcus Ventures Fund II L.P. fund, bringing the total...